During the reporting period, the company realized a total operating income of 5.406 billion yuan, an increase of 45.18 percent when compared to the previous year.
The company's operating profit was 1.116 billion yuan, a decrease of 0.18 percent on a year-on-year basis; The total profits were 1.107 billion yuan, down 2.33 percent. The net profit attributable to shareholders of the company was 939.821 million yuan, down by 1.45 percent.
Bicon’s total operating revenue surged while its net profits dropped. The company explained the reason was that the two pharmaceutical companies they acquired in 2017 have a relatively low profitability but a high turnover.
In addition, the financial expenses were adjusted in line with the newly enforced The Accounting Standards for Enterprises No. 16-Government Subsidy.
The orders for new energy products like lithium hexafluorophosphate dropped dramatically, due to the government’s policy adjustments for new energy vehi
The company's operating profit was 1.116 billion yuan, a decrease of 0.18 percent on a year-on-year basis; The total profits were 1.107 billion yuan, down 2.33 percent. The net profit attributable to shareholders of the company was 939.821 million yuan, down by 1.45 percent.
Bicon’s total operating revenue surged while its net profits dropped. The company explained the reason was that the two pharmaceutical companies they acquired in 2017 have a relatively low profitability but a high turnover.
In addition, the financial expenses were adjusted in line with the newly enforced The Accounting Standards for Enterprises No. 16-Government Subsidy.
The orders for new energy products like lithium hexafluorophosphate dropped dramatically, due to the government’s policy adjustments for new energy vehi
Latest comments